StockVS

NASDAQ · USD

OSR Health, Inc. (OSRHW) Stock Analysis

OSR Health, Inc. (OSRHW) is a stock listed on NASDAQ and quoted in US Dollar.

OSRHW

$0.03

$0.00 (0.00%)

Sep 4, 2026 · Market close

This is a derivative instrument — a warrant on OSR Health, Inc. (OSRH) common stock.

Issuer fundamentals are shown on the issuer page, not here.

View OSRH →

Price History

Hover for the daily close. The dotted line marks the period open.

OSRHW Key Statistics

As of Sep 4, 2026
Trading
Open
$0.01
Previous Close
$0.03
Day's Range
0.01–0.03
52-Week Range
0.02–0.03
Volume
2.20K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.50

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

OSRHW Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−43.40%
2025 (partial year)+0.00%

As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

About OSR Health, Inc.

OSR Health, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. The company was formerly known as OSR Holdings, Inc. and changed its name to OSR Health, Inc. in June 2026. OSR Health, Inc. was incorporated in 2020 and is based in Bellevue, Washington.

Visit website →